DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Companies / Circle Pharma, Inc.
Circle Pharma, Inc.
Facts
- Year of incorporation
- unknown
- Revenue range (Form D)
- Decline to Disclosesec.gov
- Rounds on record
- 1
- Disclosed raised
- unknownsum of rounds with a disclosed amount only
- Named investors
- 4
Financing history
1 rounds
- Jun 28, 2024Form D equity offering · $54.2M (form d sold) · 12 investorsFact SEC EDGAR Form D data sets (quarterly) · “Circle Pharma, Inc. filed Form D: $54,171,999 sold of $117,374,782, Other”
Investors on record
5 edges
- Mission Biocapital portfolio listing Fact missionbiocapital.com
- RA Capital Management, LP portfolio listing Fact racap.com
- The Column Group portfolio listing Fact thecolumngroup.com
- Lifeforce Capital Management, LLC portfolio listing Fact lifeforcecap.com
- The Column Group portfolio listing Fact thecolumngroup.com
People
2 officers, 6 directors
- David J. Earp Executive Officer/Director sec.gov
- Paul H. Park Executive Officer sec.gov
- John Josey Director Fact
- Stephen H. Kelsey Director Fact
- Matthew P. Jacobson Director Fact
- Thilo H. Schroeder Director Fact
- Walter H. Moos Director Fact
- James H. Evangelista Director Fact
Timeline
4
- Sep 16, 2026Circle Pharma, Inc. no longer listed on Lifeforce Capital Management, LLC's portfolio pageRemoved from portfolio page Inference Venture organization websites (about, team, portfolio, thesis, news pages)
- Jan 10, 2025Circle Pharma, Inc. filed Form D/A: $92,444,167 sold of $117,374,782, OtherForm D filed Fact SEC EDGAR Form D data sets (quarterly)
- Aug 29, 2024Circle Pharma, Inc. filed Form D/A: $63,171,998 sold of $117,374,782, OtherForm D filed Fact SEC EDGAR Form D data sets (quarterly)
- Jul 3, 2024Circle Pharma, Inc. filed Form D: $54,171,999 sold of $117,374,782, OtherForm D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
48 observations
Every observation on this company
- Entity type: Corporation Jan 10, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Entity type: Corporation Aug 29, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Entity type: Corporation Jul 3, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Form D industry group: Other Jan 10, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Form D industry group: Other Aug 29, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Form D industry group: Other Jul 3, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Amendment: true Jan 10, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Amendment: true Aug 29, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Amendment: false Jul 3, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Revenue range (Form D): Decline to Disclose Jan 10, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Revenue range (Form D): Decline to Disclose Aug 29, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Revenue range (Form D): Decline to Disclose Jul 3, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Incorporated: overFiveYears Jan 10, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Incorporated: overFiveYears Aug 29, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Incorporated: overFiveYears Jul 3, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Jurisdiction: DELAWARE Jan 10, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Jurisdiction: DELAWARE Aug 29, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Jurisdiction: DELAWARE Jul 3, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Amount sold (Form D): $92.4M Jan 10, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Amount sold (Form D): $63.2M Aug 29, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Amount sold (Form D): $54.2M Jul 3, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Offering amount (Form D): $117M Jan 10, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Offering amount (Form D): $117M Aug 29, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Offering amount (Form D): $117M Jul 3, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Exemptions: 06b Jan 10, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Exemptions: 06b Aug 29, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Exemptions: 06b Jul 3, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- First sale: 2024-06-28 Jan 10, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- First sale: 2024-06-28 Aug 29, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- First sale: 2024-06-28 Jul 3, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Investors (Form D): 14 Jan 10, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Investors (Form D): 14 Aug 29, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Investors (Form D): 12 Jul 3, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Minimum investment (Form D): 0 Jan 10, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Minimum investment (Form D): 0 Aug 29, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Minimum investment (Form D): 0 Jul 3, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Securities offered: equity Jan 10, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Securities offered: equity Aug 29, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Securities offered: equity Jul 3, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Office address: 681 GATEWAY BLVD, 3RD FLOOR, SOUTH SAN FRANCISCO, CA, 94080 Jan 10, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Office address: 681 GATEWAY BLVD, 3RD FLOOR, SOUTH SAN FRANCISCO, CA, 94080 Aug 29, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Office address: 681 GATEWAY BLVD, 3RD FLOOR, SOUTH SAN FRANCISCO, CA, 94080 Jul 3, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Listed on portfolio page: Mission Biocapital Sep 16, 2026 Fact Venture organization websites (about, team, portfolio, thesis, news pages)
- Listed on portfolio page: RA Capital Management, LP Sep 16, 2026 Fact Venture organization websites (about, team, portfolio, thesis, news pages)
- Listed on portfolio page: The Column Group Sep 16, 2026 Fact Venture organization websites (about, team, portfolio, thesis, news pages)
- Listed on portfolio page: Mission Biocapital Sep 15, 2026 Fact Venture organization websites (about, team, portfolio, thesis, news pages)
- Listed on portfolio page: Lifeforce Capital Management, LLC Sep 13, 2026 Fact Venture organization websites (about, team, portfolio, thesis, news pages)
- Listed on portfolio page: The Column Group Sep 12, 2026 Fact Venture organization websites (about, team, portfolio, thesis, news pages)